Depressive Disorder, Major
"Depressive Disorder, Major" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.
Descriptor ID |
D003865
|
MeSH Number(s) |
F03.600.300.375
|
Concept/Terms |
Depressive Disorder, Major- Depressive Disorder, Major
- Depressive Disorders, Major
- Disorder, Major Depressive
- Disorders, Major Depressive
- Major Depressive Disorders
- Major Depressive Disorder
Paraphrenia, Involutional- Paraphrenia, Involutional
- Involutional Paraphrenia
- Involutional Paraphrenias
- Paraphrenias, Involutional
Depression, Involutional- Depression, Involutional
- Involutional Depression
- Melancholia, Involutional
- Involutional Melancholia
|
Below are MeSH descriptors whose meaning is more general than "Depressive Disorder, Major".
Below are MeSH descriptors whose meaning is more specific than "Depressive Disorder, Major".
This graph shows the total number of publications written about "Depressive Disorder, Major" by people in this website by year, and whether "Depressive Disorder, Major" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2002 | 3 | 0 | 3 |
2004 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 4 | 2 | 6 |
2011 | 2 | 0 | 2 |
2012 | 2 | 1 | 3 |
2013 | 4 | 1 | 5 |
2014 | 4 | 0 | 4 |
2015 | 5 | 1 | 6 |
2016 | 8 | 0 | 8 |
2017 | 5 | 2 | 7 |
2018 | 7 | 0 | 7 |
2019 | 4 | 0 | 4 |
2020 | 9 | 0 | 9 |
2021 | 8 | 0 | 8 |
2022 | 4 | 0 | 4 |
2023 | 3 | 0 | 3 |
2024 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Depressive Disorder, Major" by people in Profiles.
-
Nuclear factor kappa-B cell (NF-?B), interferon regulatory Factor, and glucocorticoid receptor pathway activation in major depressive Disorder: The role of cytomegalovirus infection. Brain Behav Immun. 2025 Jan; 123:1052-1060.
-
The burden of brooding on neural error processing: The role of repetitive negative thinking in major depressive disorder with and without comorbid anxiety disorders. J Affect Disord. 2025 Jan 15; 369:27-34.
-
The unique face of comorbid anxiety and depression: Increased frontal, insula and cingulate cortex response during Pavlovian fear-conditioning. J Affect Disord. 2024 Dec 01; 366:98-105.
-
Blunted stimulus-preceding negativity during reward anticipation in major depressive disorder. J Affect Disord. 2024 Oct 01; 362:779-787.
-
Exploring the role of neuronal-enriched extracellular vesicle miR-93 and interoception in major depressive disorder. Transl Psychiatry. 2024 Apr 27; 14(1):199.
-
Impaired eating behaviors but intact metabolic hormone levels in individuals with major depressive disorder and generalized anxiety disorder. J Psychiatr Res. 2023 12; 168:193-203.
-
Elevated serum leptin is associated with attenuated reward anticipation in major depressive disorder independent of peripheral C-reactive protein levels. Sci Rep. 2023 Jul 13; 13(1):11313.
-
Real-Time fMRI Functional Connectivity Neurofeedback Reducing Repetitive Negative Thinking in Depression: A Double-Blind, Randomized, Sham-Controlled Proof-of-Concept Trial. Psychother Psychosom. 2023; 92(2):87-100.
-
Incidence and Prediction of Chronic Depression Following Aneurysmal Subarachnoid Hemorrhage: A Single-Center 17-Year Experience. World Neurosurg. 2023 Mar; 171:e206-e212.
-
C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder. Brain Behav Immun. 2022 10; 105:180-189.